BRIEF published on 10/23/2026 at 07:05, 6 days 12 hours ago BB Biotech AG Reports Strong Interim Financial Results Biotechnology Investment Company Net Profit BB Biotech AG Interim Report
BRIEF published on 10/23/2026 at 07:05, 6 days 12 hours ago BB Biotech AG annonce de solides résultats financiers intermédiaires Biotechnologie BB Biotech AG Bénéfice Net Société D'investissement Rapport Intérimaire
BRIEF published on 10/23/2026 at 07:05, 6 days 12 hours ago Perspectives de BB Biotech pour le troisième trimestre 2026 : gains et évolutions stratégiques de son portefeuille Bénéfice Net Intégration De L'IA BB Biotech 3e Trimestre 2026 Approbations De Médicaments
BRIEF published on 10/23/2026 at 07:05, 6 days 12 hours ago BB Biotech's Q3 2026: Gains and Strategic Portfolio Moves AI Integration Net Profit BB Biotech Q3 2026 Drug Approvals
PRESS RELEASE published on 10/23/2026 at 07:00, 6 days 12 hours ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes interim report for the first nine months of 2026, reporting a net profit of CHF 605 mn. Third quarter profit at CHF 175 mn Investment Company Q3 Results Net Profit BB Biotech AG Interim Report
PRESS RELEASE published on 10/23/2026 at 07:00, 6 days 12 hours ago BB Biotech Q3 2026: Positive returns, clinical progress and active portfolio redeployment BB Biotech AG reports positive returns, clinical progress, and active portfolio redeployment in Q3 2026, with a 5.6% NAV return and 6.5% share price return in CHF BB Biotech AG Returns Clinical Progress Q3 2026 Portfolio Redeployment
BRIEF published on 07/28/2026 at 15:25, 3 months 1 day ago Edison Research Analyzes BB Biotech's Robust Q2 Performance Investment Strategy Portfolio Expansion Market Outlook BB Biotech Q2 2026 Results
BRIEF published on 07/28/2026 at 15:25, 3 months 1 day ago Edison Research analyse les solides performances de BB Biotech au deuxième trimestre Stratégie D'investissement Perspectives Du Marché Expansion Du Portefeuille BB Biotech Résultats Du Deuxième Trimestre 2026
PRESS RELEASE published on 07/28/2026 at 15:20, 3 months 1 day ago Edison issues report on BB Biotech (BION) Edison issues favorable report on BB Biotech (BION) Q226 results, highlighting NAV growth, portfolio adjustments, and revised payout policy, supporting positive outlook for biotechnology investing Biotechnology Edison Report BB Biotech Q226 Results
BRIEF published on 07/24/2026 at 07:05, 3 months 5 days ago BB Biotech AG Reports Interim Gains and Adjusts Dividend Policy Dividend Policy Investment Portfolio Interim Report BB Biotech Net Gain
Published on 10/29/2026 at 18:30, 1 hour 4 minutes ago Kidoz Inc. Appoints Derek Sentner as Chief Revenue Officer
Published on 10/29/2026 at 16:05, 3 hours 29 minutes ago SouthGobi Announces Date of Special Meeting of Shareholders and The Record Date
Published on 10/29/2026 at 13:31, 6 hours 3 minutes ago First Breach Advances Ammunition and Drone Manufacturing Expansion as U.S. Reshoring Accelerates
Published on 10/29/2026 at 13:00, 6 hours 34 minutes ago NuRAN Wireless Secures US$10 Million Non-Dilutive Facility and Confirms No ATM Sales at Current Market Levels
Published on 10/29/2026 at 13:00, 6 hours 34 minutes ago Core Silver Unveils Multiple New Broad Copper-Bearing VMS Intercepts at the Touleary Discovery Zone
Published on 10/29/2026 at 19:25, 9 minutes ago EQS-Adhoc: ProSiebenSat.1 Media SE expects a slight decline in organic revenues but reaffirms EBITDA growth outlook
Published on 10/29/2026 at 19:15, 19 minutes ago TerraMaster invite les développeurs à co-développer l’écosystème TOS grâce à des récompenses pour la publication d’applications
Published on 10/29/2026 at 18:21, 1 hour 13 minutes ago EQS-Adhoc: Rubean AG: Rubean AG Strengthens Its Capital Base to Support Further Growth
Published on 10/29/2026 at 18:02, 1 hour 32 minutes ago TF1 9M 2026 results - Consolidated financial statements and appendix
Published on 10/29/2026 at 18:02, 1 hour 32 minutes ago Résultats TF1 9M 2026 - Comptes consolidés et annexes aux comptes
Published on 10/29/2026 at 18:00, 1 hour 34 minutes ago GUILLEMOT CORPORATION: THIRD-QUARTER 2026 TURNOVER / Successful new product launches and acceleration of international commercial partnerships
Published on 10/29/2026 at 18:00, 1 hour 34 minutes ago GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2026 / Succès des nouveaux lancements et accélération des partenariats commerciaux internationaux
